Similarly, compared with the MCAO group, MCAO with liproxstatin-1 treatment significantly attenuated the increase in the protein level of COX2 in mice caused by stroke (0.32 ± 0.02 vs 0.24 ± 0.05, p ≤ 0.05; n = 5, one-way ANOVA, Figures 2A,C). This evidence concerns the gene PTGS2 and stroke disorder.